Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Liabilities and Shareholders Equity (2016 - 2026)

Sensus Healthcare has reported Liabilities and Shareholders Equity over the past 11 years, most recently at $53.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 14.68% year-over-year to $53.0 million; the TTM value through Dec 2025 reached $230.4 million, down 2.97%, while the annual FY2025 figure was $53.0 million, 14.68% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $53.0 million at Sensus Healthcare, down from $58.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $62.2 million in Q4 2024 and troughed at $25.6 million in Q3 2021.
  • A 5-year average of $50.5 million and a median of $54.3 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 18.15% in 2021 and later surged 113.75% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $32.2 million in 2021, then surged by 75.98% to $56.7 million in 2022, then fell by 5.33% to $53.7 million in 2023, then increased by 15.74% to $62.2 million in 2024, then dropped by 14.68% to $53.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SRTS at $53.0 million in Q4 2025, $58.3 million in Q3 2025, and $58.9 million in Q2 2025.